<DOC>
	<DOCNO>NCT00051168</DOCNO>
	<brief_summary>Long term safety study TRAVATAN patient Open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Long-term Safety Study Once-daily Travatan</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Adult patient race either sex chronic angleclosure glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>POAG</keyword>
	<keyword>OAG</keyword>
	<keyword>OHT</keyword>
</DOC>